| RS1303126934 |
HPS1
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 1, Hermansky-Pudlak syndrome 1 |
| RS1303127476 |
SULT2B1
|
Health Risk |
Likely pathogenic |
Ichthyosis, congenital |
| RS1303129574 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1303151771 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1303165645 |
PTEN
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Melanoma |
| RS1303168294 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS1303177735 |
HADHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial trifunctional protein deficiency, Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency |
| RS1303186336 |
P3H2
|
Health Risk |
Pathogenic |
— |
| RS1303193834 |
LAMA3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1303215579 |
CACNA1S
|
Health Risk |
Pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS1303235274 |
TBCE
|
Health Risk |
Pathogenic |
— |
| RS1303254121 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1303261390 |
TYRP1
|
Health Risk |
Pathogenic |
— |
| RS1303268147 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1303270704 |
FREM2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1303279241 |
ELANE
|
Health Risk |
Conflicting classifications of pathogenicity |
Neutropenia, severe congenital |
| RS1303287747 |
PRX
|
Health Risk |
Pathogenic |
— |
| RS1303289867 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1303294230 |
SPG11
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyotrophic lateral sclerosis type 5, Hereditary spastic paraplegia |
| RS1303311376 |
INVS
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS1303324683 |
FANCI
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1303325551 |
ZSCAN10
|
Health Risk |
Pathogenic |
ZSCAN10 Deficiency, Sensorineural hearing loss disorder |
| RS1303348930 |
DHX30
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with severe motor impairment and absent language, Neurodevelopmental disorder with severe motor impairment and absent language |
| RS1303357315 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Endometrial carcinoma |
| RS1303361703 |
CLCN2
|
Health Risk |
Pathogenic |
Leukoencephalopathy with mild cerebellar ataxia and white matter edema, Leukoencephalopathy with mild cerebellar ataxia and white matter edema |
| RS1303392945 |
OCLN
|
Health Risk |
Pathogenic |
— |
| RS1303407564 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1303411209 |
KBTBD13
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 6, Nemaline myopathy 6 |
| RS1303416855 |
CEP250
|
Health Risk |
Pathogenic |
— |
| RS1303418808 |
ARID1B
|
Health Risk |
Pathogenic |
— |
| RS1303426916 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1303434565 |
ADAM22
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 61 |
| RS1303447354 |
GARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, Charcot-Marie-Tooth disease type 2 |
| RS1303453819 |
RHO
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1303454567 |
ODAD1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 20, Primary ciliary dyskinesia 20 |
| RS1303470125 |
PDCD10
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 3, Cerebral cavernous malformation 3 |
| RS1303476982 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Charcot-Marie-Tooth disease axonal type 2O |
| RS1303492021 |
GALNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-IV-A |
| RS1303557405 |
KLKB1
|
Health Risk |
Pathogenic |
Inherited prekallikrein deficiency, Inherited prekallikrein deficiency |
| RS1303559181 |
ACD
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal dominant 6 |
| RS1303561743 |
ANO10
|
Health Risk |
Pathogenic |
— |
| RS1303562049 |
GSTZ1
|
Health Risk |
Pathogenic |
Maleylacetoacetate isomerase deficiency, Maleylacetoacetate isomerase deficiency |
| RS1303564849 |
PROM1
|
Health Risk |
Pathogenic |
— |
| RS1303599332 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS1303613101 |
NR2E3
|
Health Risk |
Pathogenic/Likely pathogenic |
Enhanced S-cone syndrome, Enhanced S-cone syndrome |
| RS1303617854 |
PHKB
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IXb, Glycogen storage disease IXb |
| RS1303620777 |
STAR
|
Health Risk |
Pathogenic |
— |
| RS1303625185 |
SCAPER
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder and retinitis pigmentosa, IDDRP |
| RS1303637368 |
TNFRSF13B
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS1303653650 |
ATP13A2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Kufor-Rakeb syndrome |
| RS1303655653 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary diffuse gastric adenocarcinoma, Hereditary diffuse gastric adenocarcinoma |
| RS1303665345 |
BCL11A
|
Health Risk |
Pathogenic |
— |
| RS1303667371 |
SAMHD1
|
Health Risk |
Likely pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS1303686019 |
EYS
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1303690601 |
AMN
|
Health Risk |
Pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome |
| RS1303728412 |
CDK10
|
Health Risk |
Pathogenic |
Al Kaissi syndrome, Al Kaissi syndrome |
| RS1303732063 |
CLDN19
|
Health Risk |
Likely pathogenic |
Renal hypomagnesemia 5 with ocular involvement, Renal hypomagnesemia 5 with ocular involvement |
| RS1303748284 |
RAD50
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1303770209 |
BCKDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS1303773212 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS1303774639 |
GLB1
|
Health Risk |
Likely pathogenic |
GM1 gangliosidosis, Mucopolysaccharidosis |
| RS1303785635 |
KCNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy 5, Developmental and epileptic encephalopathy |
| RS1303788392 |
GSS
|
Health Risk |
Conflicting classifications of pathogenicity |
Inherited glutathione synthetase deficiency, Inborn genetic diseases |
| RS1303795065 |
ANKRD11
|
Health Risk |
Conflicting classifications of pathogenicity |
KBG syndrome, KBG syndrome |
| RS1303812580 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, CBL-related disorder |
| RS1303813611 |
EFHC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Absence seizure, Myoclonic epilepsy |
| RS1303817555 |
RXYLT1
|
Health Risk |
Likely pathogenic |
— |
| RS1303821903 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1303829798 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1303835934 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1303837541 |
IGHMBP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, Autosomal recessive distal spinal muscular atrophy 1 |
| RS1303840855 |
ODAD4
|
Health Risk |
Pathogenic |
Heterotaxy, Heterotaxy |
| RS1303851095 |
TBCK
|
Health Risk |
Pathogenic |
Hypotonia, infantile |
| RS1303861168 |
AAGAB
|
Health Risk |
Pathogenic |
— |
| RS1303867228 |
MCCC1
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS1303877451 |
BTD
|
Health Risk |
Pathogenic/Likely pathogenic |
Biotinidase deficiency, Biotinidase deficiency |
| RS1303879665 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS1303880423 |
SH2D1A
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked lymphoproliferative disease due to SH2D1A deficiency, X-linked lymphoproliferative disease due to SH2D1A deficiency |
| RS1303913631 |
NPR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Acromesomelic dysplasia 1, Maroteaux type |
| RS1303930496 |
ADGRV1
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2C, Usher syndrome type 2C |
| RS1303947345 |
CPA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS1303947821 |
SIX1
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 23, Autosomal dominant nonsyndromic hearing loss 23 |
| RS1303961688 |
ETFB
|
Health Risk |
Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS1303964272 |
TCTN1
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1303970751 |
LRP5
|
Health Risk |
Pathogenic |
— |
| RS1303972238 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1303980611 |
COL11A2
|
Health Risk |
Pathogenic |
— |
| RS1303988486 |
GRIN2D
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1303996018 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS1304001811 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1304003703 |
FASTKD2
|
Health Risk |
Likely pathogenic |
Combined oxidative phosphorylation deficiency 44, Combined oxidative phosphorylation deficiency 44 |
| RS1304016981 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Usher syndrome |
| RS1304024631 |
BRF1
|
Health Risk |
Likely pathogenic |
BRF1-related disorder, BRF1-related disorder |
| RS1304057833 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1304065271 |
PROM1
|
Health Risk |
Pathogenic |
Isolated macular dystrophy, Isolated macular dystrophy |
| RS1304078301 |
KANSL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS1304085334 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1304090710 |
PLEKHM1
|
Health Risk |
Likely pathogenic |
Osteopetrosis, autosomal dominant 3 |
| RS1304100342 |
MTO1
|
Health Risk |
Pathogenic |
Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency, Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency |
| RS1304104449 |
AP3B2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 48 |